Posted by Mary Helen Stoltz on February 2, 2016
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company (Symbol: VIRA) and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.Read More »
Missouri S&T is an equal opportunity/access/affirmative action/pro-disabled and veteran employer and does not discriminate on the basis of sex in our education
programs or activities, pursuant to Title IX and 34 CFR Part 106. For more information, see S&T's Nondiscrimination Policy or Equity and Title IX.